Cambridge Trust’s GSK GSK Stock Holding History

Cambridge Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$13.2K	Sell	308 -80	-21%	-$3.3K	﹤0.01%	559
2023 Q4	$14.4K	Buy	388 +80	+26%	+$2.87K	﹤0.01%	540
2023 Q3	$11.2K	Hold	308	–	–	﹤0.01%	573
2023 Q2	$11K	Sell	308 -59	-16%	-$2.12K	﹤0.01%	592
2023 Q1	$13.1K	Hold	367	–	–	﹤0.01%	601
2022 Q4	$13K	Buy	+367	New	+$12.2K	﹤0.01%	606
2022 Q3	–	Sell	-607	Closed	-$33K	–	866
2022 Q2	$33K	Sell	607 -80	-12%	-$4.42K	﹤0.01%	547
2022 Q1	$37K	Sell	687 -96	-12%	-$5.21K	﹤0.01%	577
2021 Q4	$44K	Buy	+783	New	+$40.7K	﹤0.01%	552

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Trust's GSK Position: Q1 2024 in Review

Cambridge Trust reduced its GSK (GSK) stake by 21% in Q1 2024, selling an estimated $3.3K and leaving 308 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #559.

Cambridge Trust first reported a position in GSK in Q4 2021 and has held it in 9 quarters since. The position peaked at $44K in Q4 2021. 911 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

Cambridge Trust held 308 shares of GSK worth $13.2K as of Q1 2024.
Cambridge Trust sold 80 GSK shares in Q1 2024, an estimated $3.3K.
GSK made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #559 holding.
Cambridge Trust first reported a position in GSK in Q4 2021 and has held it in 9 quarters since.
Cambridge Trust's GSK position peaked at $44K in Q4 2021.
911 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.